Inovio Pharmaceuticals Inc said its experimental Zika vaccine induced robust immune responses in an early-stage study in human volunteers who have not been infected with the virus. The company's shares rose 6.6 percent to $7.39 in premarket trading on Wednesday. The Zika virus ha…